268 related articles for article (PubMed ID: 33739548)
1. Quality of life in caregivers of patients receiving chimeric antigen receptor T-cell therapy.
Barata A; Hoogland AI; Hyland KA; Otto AK; Kommalapati A; Jayani RV; Irizarry-Arroyo N; Collier A; Rodriguez Y; Welniak TL; Booth-Jones M; Logue J; Small BJ; Jain MD; Reblin M; Locke FL; Jim HSL
Psychooncology; 2021 Aug; 30(8):1294-1301. PubMed ID: 33739548
[TBL] [Abstract][Full Text] [Related]
2. Change in Patients' Perceived Cognition Following Chimeric Antigen Receptor T-Cell Therapy for Lymphoma.
Barata A; Hoogland AI; Kommalapati A; Logue J; Welniak T; Hyland KA; Eisel SL; Small BJ; Jayani RV; Booth-Jones M; Oswald LB; Gonzalez BD; Kirtane KS; Jain MD; Mokhtari S; Chavez JC; Lazaryan A; Shah BD; Locke FL; Jim HSL
Transplant Cell Ther; 2022 Jul; 28(7):401.e1-401.e7. PubMed ID: 35580732
[TBL] [Abstract][Full Text] [Related]
3. Psychosocial interventions for informal caregivers of people living with cancer.
Treanor CJ; Santin O; Prue G; Coleman H; Cardwell CR; O'Halloran P; Donnelly M
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD009912. PubMed ID: 31204791
[TBL] [Abstract][Full Text] [Related]
4. Perception of prognosis, quality of life, and distress in patients receiving chimeric antigen receptor T-cell therapy.
Dhawale TM; Johnson PC; Gaballa MR; Nelson AM; Lavoie MW; Boateng KY; Greydanus C; Frigault MJ; El-Jawahri A
Cancer; 2023 Feb; 129(3):441-449. PubMed ID: 36457279
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal patient-reported outcomes in patients receiving chimeric antigen receptor T-cell therapy.
Johnson PC; Dhawale T; Newcomb RA; Amonoo HL; Lavoie MW; Vaughn D; Karpinski K; El-Jawahri A
Blood Adv; 2023 Jul; 7(14):3541-3550. PubMed ID: 36995091
[TBL] [Abstract][Full Text] [Related]
6. Quality of Life and Prognostic Awareness in Caregivers of Patients Receiving Chimeric Antigen Receptor T Cell Therapy.
Barata A; Dhawale T; Newcomb RA; Amonoo HL; Nelson AM; Yang D; Karpinski K; Holmbeck K; Farnam E; Frigault M; Johnson PC; El-Jawahri A
Transplant Cell Ther; 2024 Apr; 30(4):452.e1-452.e11. PubMed ID: 38242441
[TBL] [Abstract][Full Text] [Related]
7. Disparity of perception of quality of life between head and neck cancer patients and caregivers.
Kassir ZM; Li J; Harrison C; Johnson JT; Nilsen ML
BMC Cancer; 2021 Oct; 21(1):1127. PubMed ID: 34670507
[TBL] [Abstract][Full Text] [Related]
8. Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities.
Spanjaart AM; Pennings ERA; Kos M; Mutsaers PGNJ; Lugtenburg PJ; van Meerten T; van Doesum JA; Minnema MC; Jak M; van Dorp S; Vermaat JSP; van der Poel MWM; van Oijen MGH; Kuipers MT; Nijhof IS; Kersten MJ
JCO Oncol Pract; 2023 Mar; 19(3):e407-e416. PubMed ID: 36508702
[TBL] [Abstract][Full Text] [Related]
9. Patient-Reported Symptom and Functioning Status during the First 12 Months after Chimeric Antigen Receptor T Cell Therapy for Hematologic Malignancies.
Wang XS; Srour SA; Whisenant M; Subbiah IM; Chen TH; Ponce D; Gonzalez AG; Kamal M; Mendoza T; Cleland CS; Kebriaei P; Neelapu SS; Rezvani K; Ahmed S; Shpall E
Transplant Cell Ther; 2021 Nov; 27(11):930.e1-930.e10. PubMed ID: 34265479
[TBL] [Abstract][Full Text] [Related]
10. Family Caregivers' Subjective Caregiving Burden, Quality of Life, and Depressive Symptoms Are Associated With Terminally Ill Cancer Patients' Distinct Patterns of Conjoint Symptom Distress and Functional Impairment in Their Last Six Months of Life.
Wen FH; Chen JS; Chou WC; Chang WC; Shen WC; Hsieh CH; Tang ST
J Pain Symptom Manage; 2019 Jan; 57(1):64-72. PubMed ID: 30267845
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a patient-reported outcome measure to assess symptom burden after chimeric antigen receptor T-cell therapy.
Wang XS; Srour SA; Mendoza T; Whisenant M; Subbiah I; Gonzalez E; Kamal M; Shen SE; Cleeland C; Kebriaei P; Rezvani K; Neelapu S; Ahmed S; Shpall E
Br J Haematol; 2023 May; 201(4):738-746. PubMed ID: 36733986
[TBL] [Abstract][Full Text] [Related]
12. Experiences and perspectives on chimeric antigen receptor (CAR) T-cell therapy among recipients, carers and referrers (RE-TELL): a qualitative study to inform CAR T-cell service design.
Fyfe R; Anstis O; Kapadia K; Jordan M; Sword DO; Weinkove R
BMJ Open; 2024 Jan; 14(1):e071112. PubMed ID: 38262637
[TBL] [Abstract][Full Text] [Related]
13. Multi-Stakeholder Qualitative Interviews to Inform Measurement of Patient Reported Outcomes After CAR-T.
Akinola IM; Cusatis R; Pasquini MC; Shaw BE; Bollu V; Dalal A; Tesfaye M; Flynn KE
Transplant Cell Ther; 2023 Apr; 29(4):254.e1-254.e9. PubMed ID: 36634738
[TBL] [Abstract][Full Text] [Related]
14. The relationship between caregivers' global ratings of Alzheimer's disease patients' quality of life, disease severity, and the caregiving experience.
Karlawish JH; Casarett D; Klocinski J; Clark CM
J Am Geriatr Soc; 2001 Aug; 49(8):1066-70. PubMed ID: 11555068
[TBL] [Abstract][Full Text] [Related]
15. Informal caregiver well-being during and after patients' treatment with adjuvant chemotherapy for colon cancer: a prospective, exploratory study.
Langenberg SMCH; Poort H; Wymenga ANM; de Groot JW; Muller EW; van der Graaf WTA; Prins JB; van Herpen CML
Support Care Cancer; 2021 May; 29(5):2481-2491. PubMed ID: 32935205
[TBL] [Abstract][Full Text] [Related]
16. A qualitative service evaluation of patient and caregiver experiences of CAR-T therapy: Recommendations for service development and implications for palliative care teams.
Stenson CL; Vidrine J; Dewhurst F; Osborne W; Menne T; Stocker R
Palliat Med; 2023 Feb; 37(2):215-220. PubMed ID: 36428287
[TBL] [Abstract][Full Text] [Related]
17. Telephone interventions, delivered by healthcare professionals, for providing education and psychosocial support for informal caregivers of adults with diagnosed illnesses.
Corry M; Neenan K; Brabyn S; Sheaf G; Smith V
Cochrane Database Syst Rev; 2019 May; 5(5):CD012533. PubMed ID: 31087641
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal Patient Reported Outcomes with CAR-T Cell Therapy Versus Autologous and Allogeneic Stem Cell Transplant.
Sidana S; Dueck AC; Thanarajasingam G; Griffin JM; Thompson C; Durani U; Burtis M; Warsame R; Paludo J; Gertz MA; Dispenzieri A; Ansell SM; Rajkumar SV; Yost K; Bennani N; Lin Y; Kumar S
Transplant Cell Ther; 2022 Aug; 28(8):473-482. PubMed ID: 35550440
[TBL] [Abstract][Full Text] [Related]
19. Improving Sexual and Gender Minority Cancer Care: Patient and Caregiver Perspectives From a Multi-Methods Pilot Study.
Kano M; Jaffe SA; Rieder S; Kosich M; Guest DD; Burgess E; Hurwitz A; Pankratz VS; Rutledge TL; Dayao Z; Myaskovsky L
Front Oncol; 2022; 12():833195. PubMed ID: 35600396
[TBL] [Abstract][Full Text] [Related]
20. Caregiver burden and emotional wellbeing in informal caregivers to ICU survivors-A prospective cohort study.
Milton A; Schandl A; Larsson IM; Wallin E; Savilampi J; Meijers K; Joelsson-Alm E; Bottai M; Sackey P
Acta Anaesthesiol Scand; 2022 Jan; 66(1):94-102. PubMed ID: 34582048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
